Page last updated: 2024-09-05

zm 241385 and sch 23390

zm 241385 has been researched along with sch 23390 in 1 studies

Compound Research Comparison

Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010)
(zm 241385)
Studies
(sch 23390)
Trials
(sch 23390)
Recent Studies (post-2010) (sch 23390)
40131248030585

Protein Interaction Comparison

ProteinTaxonomyzm 241385 (IC50)sch 23390 (IC50)
D(2) dopamine receptorHomo sapiens (human)1.0405
DRattus norvegicus (Norway rat)0.001
D(1A) dopamine receptorHomo sapiens (human)0.0461
D(1B) dopamine receptorHomo sapiens (human)0.0011
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0006
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.3891

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO1

Other Studies

1 other study(ies) available for zm 241385 and sch 23390

ArticleYear
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Journal of medicinal chemistry, 2005, Nov-03, Volume: 48, Issue:22

    Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles

2005